Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | FDPS | P14324 | 3/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1403820 | 1.00 | ZDHHC7 (0.39) | ZDHHC7LMNADNM1TSHRTHRB | |
| SCHEMBL28783515 | 1.00 | ZDHHC7 (0.39) | ZDHHC7LMNADNM1TSHRTHRB | |
| SCHEMBL28997703 | 1.00 | ZDHHC7 (0.39) | ZDHHC7LMNADNM1TSHRTHRB | |
| SCHEMBL11213771 | 1.00 | ZDHHC7 (0.39) | ZDHHC7LMNADNM1TSHRTHRB | |
| SCHEMBL1479600 | 1.00 | ZDHHC7 (0.39) | ZDHHC7LMNADNM1TSHRTHRB | |
| SCHEMBL1515460 | 1.00 | ZDHHC7 (0.39) | ZDHHC7LMNADNM1TSHRTHRB | |
| SCHEMBL20476454 | 0.98 | ZDHHC7 (0.38) | ZDHHC7LMNADNM1TSHRTHRB | |
| Hydrochloric Acid SCHEMBL18038654 | 0.96 | ZDHHC7 (0.37) | ZDHHC7LMNADNM1TSHRTHRB | |
| SCHEMBL19532759 | 0.93 | OPRM1 (0.36) | ZDHHC7LMNADNM1TSHRTHRB | |
| SCHEMBL22721264 | 0.91 | ZDHHC7 (0.37) | ZDHHC7LMNADNM1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12535748-B2 | Magnetic toner | CANON KABUSHIKI KAISHA (JP) | 2026-01-27 | — | — | US | disclosed |
| US-20230122974-A1 | MAGNETIC TONER | CANON KABUSHIKI KAISHA (JP) | 2023-04-20 | — | — | US | disclosed |
| EP-1357437-B1 | Process for producing toner particles | CANON KK (JP) | 2010-03-10 | — | — | EP | disclosed |
| US-6953648-B2 | Process for producing toner particles | CANON KABUSHIKI KAISHA (JP) | 2005-10-11 | — | — | US | disclosed |
| US-20030232269-A1 | Process for producing toner particles | CANON KABUSHIKI KAISHA (JP) | 2003-12-18 | — | — | US | disclosed |
| EP-1357437-A2 | Process for producing toner particles | CANON KABUSHIKI KAISHA (JP) | 2003-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12535748-B2 | Magnetic toner | SMC2, SMC1A, SMC4 | ZDHHC7 3463/4885LMNA 2857/4885DNM1 1756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.